Cardiology

Research from investigators in Spain suggests increased BMI was associated with the prevalence of cardiovascular disease risk factors regardless of a patient's physical activity levels.

Dr. Gregory Weiss reflects on his experience receiving the Pfizer COVID-19 vaccine and his thoughts on the ongoing rollout process.

An analysis of data and blood samples from more than 28k women provides insight into the predictive value of more than 50 biomarkers for predicting risk of premature coronary heart disease in aging women.

Data from an analysis of more than 3k women indicate increased frequency of vasomotor menopausal symptoms was associated with a 52% greater risk of incident cardiovascular disease.

The clinical presentation of influenza myocarditis includes, fever, myalgia, palpitations, shortness of breath, and chest pains.

Check out our latest case report from Dr. Brady Pregerson, which features a smoker in her 60 with a history of COPD presenting with 6 days of vomiting and diarrhea and 1 day of constant LLQ pain. Can you determine the correct diagnosis?

The guidelines list more than 40 recommendations related to blood pressure targets, screening and diagnosis, and overall cardiovascular disease risk management strategies.

An analysis of data from more than 3k women followed for up to 20 years indicates increased frequency of vasomotor menopausal symptoms was associated with a 52% greater risk of incident cardiovascular disease.

The association between genetic liability to smoking and ASCVD was independent from the effects of smoking on traditional cardiovascular risk factors.

Findings from a 1-sample Mendelian randomization study using data from the UK Biobank revealed a causal link between smoking and the risk of subarachnoid hemorrhage.

An analysis of the Women's Health Study indicates women with type 2 diabetes were at a 10-times greater risk of developing premature coronary heart disease than their counterparts without diabetes.

The approval is the first indication for a new pathway of care—one which has been linked to reduced heart failure death and hospitalization.

While social media and technology have allowed greater sharing of ideas and knowledge, they have also become a major source of misinformation. In this column, Dr. Weiss reflects on practicing during the age of misinformation.

A high fasting insulin level trajectory was associated with psychosis, while puberty-onset BMI increase was linked to depression.

A phase 2 study suggests treating the common diabetes comorbidity may be capable with the monoclonal antibody.

Results from a systematic review and meta-analysis of more than 50 studies assessing cardiovascular risk with levels of abdominal aortic calcification indicate increased AAC was linked to 80% increase in risk of cardiovascular events and cardiovascular death.

An analysis of data from the UK Biobank cohort offers an overview of the risk reduction for cardiovascular disease derived from various levels and measurements of physical activity.

Data from questionnaires given to type 1 and type 2 diabetes patients from an outpatient clinic is providing insight into how the COVID-19 pandemic has impacted diabetes management.

A quality improvement study conducted at a trio of Penn Medicine hospitals suggests changing cardiac rehabilitation referrals from an opt-in to an opt-out decision in their EHR could drastically improve referral rates.

The SOLOIST-WHF trial indicates that SGLT2 inhibition may lead to an overall reduction in cardiovascular-related deaths and hospitalizations.

An analysis of nearly 100k people from the UK Biobank study suggests there was no upper threshold on the reduction in risk of cardiovascular disease derived from physical activity.

An analysis of more than 100k people from five community-based cohorts indicates consuming one alcoholic drink per day could increase risk of atrial fibrillation by 16%, while consuming four per day increased risk by 47%.

A conversation on how associations between the chronic conditions have become better understood in 10 years.

In this column, Dr. Paul Thompson offers his perspective on the use of digoxin and explains why he has maintained use in certain patient populations despite its waning popularity in recent years.

An analysis by clinicians from Beth Israel Deaconess Medical Center provides an overview of the increase in cardiac deaths occurring as a result of avoiding emergency departments during the COVID-19 pandemic.